US
US Menopause Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $1.29 Bn.
Canada at 7.3% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$658.7 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.23 Bn | — | — |
| 2025 (base) | $1.29 Bn | +$57.8 Mn | — |
| 2026 (forecast) | $1.35 Bn | +$60.5 Mn | +4.7% |
| 2027 (forecast) | $1.41 Bn | +$63.3 Mn | +9.6% |
| 2028 (forecast) | $1.48 Bn | +$66.3 Mn | +14.8% |
| 2029 (forecast) | $1.55 Bn | +$69.4 Mn | +20.2% |
| 2030 (forecast) | $1.62 Bn | +$72.7 Mn | +25.8% |
| 2031 (forecast) | $1.70 Bn | +$76.1 Mn | +31.7% |
| 2032 (forecast) | $1.77 Bn | +$79.7 Mn | +37.9% |
| 2033 (forecast) | $1.86 Bn | +$83.4 Mn | +44.4% |
| 2034 (forecast) | $1.95 Bn | +$87.3 Mn | +51.2% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$1.29 Bn
China
$253.0 Mn
Canada
$246.2 Mn
Japan
$236.7 Mn
Germany
$111.6 Mn
France
$107.4 Mn
Brazil
$94.4 Mn
UK
$87.4 Mn
Italy
$88.6 Mn
Ecuador
$78.6 Mn
India
$63.5 Mn
Spain
$57.5 Mn
Mexico
$57.8 Mn
Saudi Arabia
$54.8 Mn
Australia
$41.0 Mn
New Zealand
$31.1 Mn
Russia
$30.8 Mn
South Africa
$26.1 Mn
UAE
$18.0 Mn
Egypt
$9.2 Mn
Philippines
$7.8 Mn
Malaysia
$6.4 Mn
Hong Kong
$6.2 Mn
Singapore
$4.0 Mn
Thailand
$3.8 Mn
Kenya
$2.2 Mn
Menopause supplements contain herbs, vitamins and plant compounds marketed to ease hot flashes, mood changes and bone loss.
Key segments of the menopause Supplements market include ingredient (Black Cohosh, Soy Isoflavones and Vitamin D and Calcium) and form (Capsules, Gummies and Powders).
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the menopause Supplements market. New products designed around women's biology and digital care are improving access.
Femtech, personalised care and new treatments for under-served conditions open strong growth for the menopause Supplements market, especially as employers and payers add women's health benefits.
Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the menopause Supplements market.
The menopause Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Food and supplement rules, labelling and health-claim regulations govern menopause Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in US.
What doctors and scientists are doing in Menopause Supplements right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
US · 5 shared keywords
US · 3 shared keywords
US · 3 shared keywords
US · 3 shared keywords
US · 3 shared keywords
US · 3 shared keywords
Pharmaceuticals · US
Healthcare Services · US
Pharmaceuticals · US
Medical Devices · US
Pharmaceuticals · US
Pharmaceuticals · US